BioWorld MedTech

July 14, 2011

Deals roundup: Private consortium set to pay $6.3 billion for Kinetic Concepts

A group of private equity investors have officially offered to buy Kinetic Concepts (KCI; San Antonio) for $68.50 a share in a cash deal valued at $6.3 billion (including KCI's outstanding debt). (Medical Device Daily) Read More

St. Jude Medical receives FDA approval for Epiducer

International report: EarlySense monitoring system now cleared for sale in Canada

Washington roundup: Foster; 'little incentive for cost-reducing technology'

Financings roundup: InSite to take part in private placement for $22.2 million

MDD's food for med-tech thought

People in the News

HIT roundup: Sermo launches new mobile application for physicians

Court Report: Acacia subsidiary settles with Boston Sci in patent dispute

Med-Tech Notes

Patent watch: Molecular Detection receives notice for antibiotic bacteria

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 12, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...